Medicine, Hematology Oncology Division

Fingerprint Dive into the research topics where Medicine, Hematology Oncology Division is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Kehinde Adekola

    Kehinde Adekola

    Person: Academic

    20122020
    No photo of Mark Agulnik

    Mark Agulnik

    Person: Academic

    20012020
    No photo of Jessica K Altman

    Jessica K Altman

    Person: Academic

    20052020

    Research Output

    6mer Seed Toxicity in Viral microRNAs

    Murmann, A. E., Bartom, E. T., Schipma, M. J., Vilker, J., Chen, S. & Peter, M. E., Feb 21 2020, In : iScience. 23, 2, 100737.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    A case report of multiple primary prostate tumors with differential drug sensitivity

    Wilkinson, S., Harmon, S. A., Terrigino, N. T., Karzai, F., Pinto, P. A., Madan, R. A., VanderWeele, D. J., Lake, R., Atway, R., Bright, J. R., Carrabba, N. V., Trostel, S. Y., Lis, R. T., Chun, G., Gulley, J. L., Merino, M. J., Choyke, P. L., Ye, H., Dahut, W. L., Turkbey, B. & 1 others, Sowalsky, A. G., Dec 1 2020, In : Nature communications. 11, 1, 837.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    Acute megakaryocytic leukemia

    McNulty, M. & Crispino, J. D., Feb 2020, In : Cold Spring Harbor Perspectives in Medicine. 10, 2, a034884.

    Research output: Contribution to journal › Article

    • Grants

    Mechanisms of transformation and therapy resistance in myelodysplastic syndrome and acute myeloid leukemia

    Crispino, J. D.

    ASCO Cancer Foundation

    7/1/20 → 6/30/21

    Project: Research project

    • Prot #IMGN632-0802: A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

    Altman, J. K.

    Precision Oncology, LLC, ImmunoGen, Inc.

    6/4/20 → 6/4/23

    Project: Research project

    Prot #20170528: A Phase 1 First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

    Altman, J. K.

    Amgen, Inc.

    6/3/20 → 6/3/23

    Project: Research project